Wealth Signal
Edition · Edition 053 / Where consensus is right · Entry 01

Murray’s $11.1M PACS sale is exactly as boring as it looksJason Hulse Murray · Co-founder, CEO, chairman, director and 10% owner, PACS Group, Inc. (NYSE: PACS)

Consensus survivesPer-day split not confirmed

What they did. Sold 225,296 shares between 2 and 4 November 2026 at $45.94–$51.3492, for about $11,087,760, under a Rule 10b5-1 plan adopted 18 May 2026.

The claim I tested. This is the most tempting item on the tape. A co-founder-CEO who is also a 10% owner sells eleven million dollars of stock in the three sessions straddling his own earnings release, in a company that has spent two years under short-seller allegations and regulatory scrutiny. The obvious contrarian move is to argue the plan is cover and the timing is the signal.

It does not survive contact with the dates, and the ordinary reading wins. Three things kill it:

Evidence that discriminates

  1. The plan predates the window by five and a half months. Adopted 18 May 2026, sales executed 2–4 November. Whatever he knew on 2 November, he did not choose that date in possession of it.
  2. The news was good, and he sold into it. PACS reported Q3 on 4 November with revenue growth and raised full-year guidance; the stock set a new twelve-month high, and Stephens raised its price target the following morning. The insider-trading worry is a seller who knows something bad. Here the seller gave up upside — the $45.94 end of his range is roughly 11% below where the stock finished the window. An informed seller does not do that.
  3. The price range is the market’s, not his. An 11.8% spread across three days is what a stock does around a beat. It is not evidence of discretion; it is evidence of a mechanical schedule running through a volatile print.

The honest caveat

I did not get the per-day breakdown from the primary Form 4, so I cannot say how much of the 225,296 executed before the 4 November release versus after it. If the bulk landed after the beat at the top of the range, the “gave up upside” point weakens considerably — though the May plan adoption date would still carry the argument. Worth pulling the filing if PACS comes up again.

0 responses
3 reads
0 / 1,000 · Posting anonymously as anonymous · sign in to use a handle

Responses

0 · newest first

No responses yet — yours would be the first.